HighTide Therapeutics (“HighTide”), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for non-viral chronic liver diseases, gastrointestinal diseases, and metabolic disorders, announced that its
May 26, 2021
Learn more
HighTide Therapeutics (“HighTide”), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for non-viral chronic liver diseases, gastrointestinal diseases
April 28, 2021
Learn more
HighTide Therapeutics today announced that the Company will present at the fifth annual NASH-TAG Conference. The hybrid (in-person/virtual) conference, focused on therapeutic agents for non-alcoholic steatohepatitis (NASH) and liver fibrosis
March 03, 2021
Learn more
We will contact you as soon as possible
© 2020 HighTide Therapeutics Inc.